Bio/Pharma News

Sanofi Launches First Public Dengue Immunization Program

April 11, 2016

Sanofi says the program will vaccinate one million students from 6000 public schools in dengue-epidemic regions of the Philippines.

Report Examines Price Increases on Most Widely Used Drugs in US

April 08, 2016

A report by Reuters found that four of the top 10 most widely used drugs increased 100% since 2011, while the other six increased 60%.

FDA Approves First mAb Biosimilar

April 06, 2016

Inflectra is the second biosimilar to hit the market in the United States.

Pfizer and Allergan Terminate Merger Agreement

April 06, 2016

The companies announced that they have mutually decided to terminate the planned merger after the US Department of Treasury and the IRS issue temporary and proposed regulations on tax inversion.

Samsung Bioepis’ Flixabi Receives Positive Recommendation from CHMP

April 04, 2016

The company received a positive recommendation for it’s Remicade biosimilar, Flixabi (infliximab).

GE Healthcare Launches New Research Scheme in Turkey

March 30, 2016

The new research scheme will be based in GE’s Turkey-based innovation center, and will help support the region’s biopharmaceutical industry.

Boehringer Ingelheim Enters Commercial Partnership with Propeller Health

March 29, 2016

The commercial partnership aims to use digital health tools including sensors, apps, analytics, personal feedback, and education to assist patients in monitoring respiratory diseases.

Novo Nordisk Builds Manufacturing Facility in North Carolina

March 29, 2016

Novo Nordisk broke ground on a facility in Clayton, NC, to manufacture APIs for GLP-1 and insulin medicines.

Bristol-Myers Squibb Collaborates with Bioprocessing Institute in Ireland

March 29, 2016

A team of Bristol-Myers Squibb scientists will work in a new laboratory at the National Institute of Bioprocessing Research and Training facility in Dublin, Ireland.

CMC Biologics and IDT Biologika Collaborate on ADC Manufacturing

March 24, 2016

PTSM: Pharmaceutical Technology Sourcing and Management

Collaboration will provide for unified development and manufacture of antibody drug conjugates.